Cargando…
The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
Active surveillance (AS) is a considered treatment option for men with low or very low-risk prostate cancer. However, on repeat biopsy some 25% were upgraded and recommended for active treatment. We compare the presence or absence of primary circulating prostate cells (CPCs) with the clinical pathol...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243134/ https://www.ncbi.nlm.nih.gov/pubmed/28144285 http://dx.doi.org/10.3332/ecancer.2017.711 |